Arboretum LifeSciences develops genetic testing, research registry, and precision medicine programs for common diseases.
arboretum lifesciences has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
arboretum lifesciences's investors include .406 Ventures, Amgen, Hims, F-Prime, Google Ventures.
arboretum lifesciences is headquartered in Boston, United States.
Arboretum LifeSciences develops genetic testing, research registry, and precision medicine programs for common diseases.
arboretum lifesciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"arboretum lifesciences — Funding & Investors." VCBacked, October 6, 2026, https://www.vcbacked.co/company/arboretum-lifesciences. Accessed November 2, 2026.
VCBacked. (2026). arboretum lifesciences — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/arboretum-lifesciences
{{cite web |title=arboretum lifesciences — Funding & Investors |url=https://www.vcbacked.co/company/arboretum-lifesciences |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at arboretum lifesciences? Request a listing update